Delivery Order SPE2DB22D2108-SPE2DB25FU4CF

Award Date 4/15/25
Potential Completion Date 4/16/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,791.50, is for the procurement of ARANESP 25 MCG/0.42 ML SYRING 0.42ML, a specialty pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of June 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ARANESP 100 MCG/0.5 ML SYRINGE 0.5ML. The award has a total ceiling value of $16,141.52 and an ultimate completion date of April 15, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ARANESP 500 MCG/1 ML SYRINGEML, a medication, with a ceiling value of $12,222.04 and a performance period through May 8, 2025. The contract is a firm fixed-price, non-set-aside vehicle, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,376.14, is for the delivery of ARANESP 60 MCG/0.3 ML SYRINGE 0.3ML, a specialty medication. This is a Firm Fixed Price Delivery Order contract with a completion date of January 22, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,759.17 firm fixed-price contract is for the supply of ARANESP 100 MCG/0.5 ML SYRINGE 0.5ML, a specialty medication, to support military healthcare programs. The contract is not designated with a set-aside requirement, indicating open competition. It is associated with a larger Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for ARANESP 500 MCG/1 ML SYRINGEML, a pharmaceutical product, with a ceiling value of $15,692.01 and a completion date of November 24, 2023. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,553.92 delivery order contract is for the supply of ARANESP 200 MCG/0.4 ML SYRINGE 0.4ML, a specialty medication. The contract is a Firm Fixed Price arrangement with a performance period through March 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) between...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,182.78, is for the supply of ARANESP 500 MCG/1 ML SYRINGEML, a prescription medication. The contract has a firm fixed price pricing type and an ultimate completion date of April 7, 2025. It is not a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ARANESP 500 MCG/1 ML SYRINGEML, a specialty pharmaceutical product, with a ceiling value of $10,521.48. The contract is a firm fixed price contract with a period of performance through March 6, 2025. This contract was not designated as a set-aside and was awarded through open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,105.96 and is a Firm Fixed Price Delivery Order for the supply of the medication ARANESP 200 MCG/0.4 ML SYRINGE 0.4ML. The contract has an ultimate completion date of January 31, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D2108
    Indefinite Delivery Contract
  • SPE2DB22D2108-SPE2DB25FU4CF
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,300.60, is for the delivery of ARANESP 150 MCG/0.3 ML SYRINGE 0.3ML, a prescription medication.

The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999.00. This IDC provides a comprehensive global pharmaceutical support vehicle for the DLA, U.S. Coast Guard, and other government agencies, allowing AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military and veteran healthcare programs.

The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and the award has an ultimate completion date of April 16, 2025.

Generated 7/15/25, 3:18 PM